BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12388820)

  • 1. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
    Symons JA; Adams E; Tscharke DC; Reading PC; Waldmann H; Smith GL
    J Gen Virol; 2002 Nov; 83(Pt 11):2833-2844. PubMed ID: 12388820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.
    Reading PC; Smith GL
    J Virol; 2003 Sep; 77(18):9960-8. PubMed ID: 12941906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.
    Symons JA; Tscharke DC; Price N; Smith GL
    J Gen Virol; 2002 Aug; 83(Pt 8):1953-1964. PubMed ID: 12124459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model.
    Kettle S; Blake NW; Law KM; Smith GL
    Virology; 1995 Jan; 206(1):136-47. PubMed ID: 7831769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
    Reading PC; Khanna A; Smith GL
    Virology; 2002 Jan; 292(2):285-98. PubMed ID: 11878931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
    Reading PC; Symons JA; Smith GL
    J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.
    Tscharke DC; Reading PC; Smith GL
    J Gen Virol; 2002 Aug; 83(Pt 8):1977-1986. PubMed ID: 12124461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model.
    Gardner JD; Tscharke DC; Reading PC; Smith GL
    J Gen Virol; 2001 Sep; 82(Pt 9):2083-2093. PubMed ID: 11514717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.
    Kettle S; AlcamĂ­ A; Khanna A; Ehret R; Jassoy C; Smith GL
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():677-85. PubMed ID: 9049422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
    de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model.
    Pires de Miranda M; Reading PC; Tscharke DC; Murphy BJ; Smith GL
    J Gen Virol; 2003 Sep; 84(Pt 9):2459-2471. PubMed ID: 12917467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence.
    Bartlett N; Symons JA; Tscharke DC; Smith GL
    J Gen Virol; 2002 Aug; 83(Pt 8):1965-1976. PubMed ID: 12124460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication.
    Almazán F; Tscharke DC; Smith GL
    J Virol; 2001 Aug; 75(15):7018-29. PubMed ID: 11435582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo.
    Vijaysri S; Talasela L; Mercer AA; Mcinnes CJ; Jacobs BL; Langland JO
    Virology; 2003 Sep; 314(1):305-14. PubMed ID: 14517083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
    Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
    Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
    Parkinson JE; Sanderson CM; Smith GL
    Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence.
    Ng A; Tscharke DC; Reading PC; Smith GL
    J Gen Virol; 2001 Sep; 82(Pt 9):2095-2105. PubMed ID: 11514718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection.
    Reading PC; Moore JB; Smith GL
    J Exp Med; 2003 May; 197(10):1269-78. PubMed ID: 12756265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M; Smith GL
    Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.